Repligen Corporation to Present at Wells Fargo Healthcare Conference
Repligen (NASDAQ:RGEN), a leading bioprocessing technology company in the life sciences sector, has announced its participation in the upcoming Wells Fargo Healthcare Conference. The event is scheduled to take place from September 4-6 in Boston.
Olivier Loeillot, Repligen's President and CEO, will engage in an analyst-led discussion on Friday, September 6, at 8:45 a.m. ET. Investors and interested parties can access a live webcast of the presentation through Repligen's Investor Relations website at www.repligen.com. The replay of the presentation will be available for a time after the event.
This conference provides Repligen with an opportunity to showcase its latest developments and strategic initiatives in the bioprocessing technology field to investors and industry analysts.
Repligen (NASDAQ:RGEN), una delle principali aziende di tecnologia bioprocessing nel settore delle scienze della vita, ha annunciato la sua partecipazione al prossimo Wells Fargo Healthcare Conference. L'evento si terrà dal 4 al 6 settembre a Boston.
Olivier Loeillot, Presidente e CEO di Repligen, parteciperà a una discussione guidata da analisti venerdì 6 settembre, alle 8:45 a.m. ET. Gli investitori e le parti interessate possono accedere a un webcast in diretta della presentazione attraverso il sito web delle Relazioni con gli Investitori di Repligen all'indirizzo www.repligen.com. La registrazione della presentazione sarà disponibile per un certo tempo dopo l'evento.
Questa conferenza offre a Repligen l'opportunità di presentare i suoi ultimi sviluppi e iniziative strategiche nel campo della tecnologia bioprocessing a investitori e analisti del settore.
Repligen (NASDAQ:RGEN), una empresa líder en tecnología de bioprocesamiento en el sector de ciencias de la vida, ha anunciado su participación en la próxima Wells Fargo Healthcare Conference. El evento está programado para llevarse a cabo del 4 al 6 de septiembre en Boston.
Olivier Loeillot, Presidente y CEO de Repligen, participará en una discusión dirigida por analistas el viernes 6 de septiembre, a las 8:45 a.m. ET. Los inversionistas y partes interesadas pueden acceder a una transmisión en vivo de la presentación a través del sitio web de Relaciones con Inversionistas de Repligen en www.repligen.com. La repetición de la presentación estará disponible por un tiempo después del evento.
Esta conferencia ofrece a Repligen la oportunidad de mostrar sus últimos desarrollos e iniciativas estratégicas en el campo de la tecnología de bioprocesamiento a inversionistas y analistas de la industria.
Repligen (NASDAQ:RGEN)는 생명 과학 분야의 주요 바이오 프로세싱 기술 회사로, 곧 열릴 웰스파고 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 이 행사는 9월 4일부터 6일까지 보스턴에서 진행됩니다.
Repligen의 대통령이자 CEO인 Olivier Loeillot는 9월 6일 금요일 오전 8:45 (동부 표준시)에 애널리스트 주도의 토론에 참여할 예정입니다. 투자자 및 관심 있는 당사자들은 Repligen의 투자자 관계 웹사이트 www.repligen.com를 통해 발표의 실시간 웹캐스트에 접근할 수 있습니다. 발표의 재생은 행사 후 일정 기간 동안 제공될 것입니다.
이번 컨퍼런스는 Repligen가 바이오 프로세싱 기술 분야에서의 최신 개발과 전략적 이니셔티브를 투자자 및 업계 애널리스트에게 소개할 수 있는 기회를 제공합니다.
Repligen (NASDAQ:RGEN), une entreprise leader dans la technologie de bioprocédés dans le secteur des sciences de la vie, a annoncé sa participation à la prochaine Wells Fargo Healthcare Conference. L'événement est prévu du 4 au 6 septembre à Boston.
Olivier Loeillot, Président et CEO de Repligen, participera à une discussion dirigée par des analystes le vendredi 6 septembre à 8h45 (ET). Les investisseurs et les parties intéressées peuvent accéder à un webinaire en direct de la présentation via le site web des relations investisseurs de Repligen à l'adresse www.repligen.com. Le replay de la présentation sera disponible pendant un certain temps après l'événement.
Cette conférence offre à Repligen l'opportunité de présenter ses derniers développements et initiatives stratégiques dans le domaine de la technologie de bioprocédés aux investisseurs et aux analystes du secteur.
Repligen (NASDAQ:RGEN), ein führendes Unternehmen für Bioprozess-Technologie im Bereich der Lebenswissenschaften, hat seine Teilnahme an der bevorstehenden Wells Fargo Healthcare Conference bekannt gegeben. Die Veranstaltung findet vom 4. bis 6. September in Boston statt.
Olivier Loeillot, Präsident und CEO von Repligen, wird an einer von Analysten geleiteten Diskussion am Freitag, den 6. September, um 8:45 Uhr ET teilnehmen. Investoren und Interessierte können die Live-Übertragung der Präsentation über die Investor Relations-Website von Repligen unter www.repligen.com abrufen. Die Aufzeichnung der Präsentation wird für einige Zeit nach der Veranstaltung verfügbar sein.
Diese Konferenz bietet Repligen die Möglichkeit, den Investoren und Branchenanalysten die neuesten Entwicklungen und strategischen Initiativen im Bereich der Bioprozess-Technologie vorzustellen.
- None.
- None.
WALTHAM, Mass., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be presenting at the Wells Fargo Healthcare Conference being held September 4-6 in Boston. Olivier Loeillot, President and Chief Executive Officer will participate in an analyst-led discussion on Friday, September 6, at 8:45 a.m. ET.
A live webcast of the conference presentation will be accessible through Repligen’s Investor Relations website at www.repligen.com, and will be available for replay for a limited period of time following the event.
About Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are “inspiring advances in bioprocessing” for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Our corporate headquarters are located in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U.S., with additional key sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden. For more information about the our company see our website at www.repligen.com, and follow us on LinkedIn.
Repligen Contact:
Sondra S. Newman
Global Head of Investor Relations
(781) 419-1881
investors@repligen.com
FAQ
When is Repligen (RGEN) presenting at the Wells Fargo Healthcare Conference?
Who will be representing Repligen (RGEN) at the Wells Fargo Healthcare Conference?
How can investors access Repligen's (RGEN) presentation at the Wells Fargo Healthcare Conference?
What dates is the Wells Fargo Healthcare Conference being held?
Will a replay of Repligen's (RGEN) presentation be available after the conference?
